/
/
/

Astal Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Mar 2025
₹101 Cr₹134 Cr₹23 Cr
₹14 L₹10 L₹4 L
₹101 Cr₹134 Cr₹24 Cr
₹90 Cr₹125 Cr₹19 Cr
₹12 Cr₹10 Cr₹4 Cr
₹1 Cr₹1 Cr₹27 L
₹10 Cr₹8 Cr₹4 Cr
₹9 Cr₹8 Cr₹3 Cr

Share Price Live Stats

Open (₹)76.90
Volume (₹)22,586.00
High (₹)77.40
Upper Circuit92.28
Low (₹)62.80
Lower Circuit61.52
Prev Close76.90
52W High (₹)103.20
Price74.00
52W Low (₹)60.45

Share Market Cap & Key Ratios Overview

M.Cap (₹)336.81 Cr
Div. Yield (%)0.00
PE Ratio34.60
Debt to Equity0.41
Price to Book2.32
Book Value32.81
EPS (TTM)2.22
Face Value10.00
ROE (%)32.12

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
CIPLA-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
ASTALLTD-XNSE
LTP
1W Low
1W High
Market cap (₹)
1891.95-41.05 (-2.12%)
1887.25
1934
4,55,634Cr
9265+33 (0.36%)
9100
9288
2,41,576Cr
4886.4-118 (-2.36%)
4822.25
5048.55
1,84,478Cr
1382.5-30.65 (-2.17%)
1375.85
1415
1,11,888Cr
1152.1+0.9 (0.08%)
1110.55
1162.50
1,11,820Cr
1860.05-2.95 (-0.16%)
1826.95
1875
99,418Cr
2110.4-42.2 (-1.96%)
2100
2170
96,529Cr
1154.15-6.85 (-0.59%)
1142.55
1165.75
96,322Cr
2324-56 (-2.35%)
2305.10
2381
96,180Cr
1658.35+2.05 (0.12%)
1623.05
1666.60
95,127Cr
74-4.37 (-5.58%)
62.80
80.35
337Cr

Key Highlights of Astal Laboratories Ltd’s P&L

In 2025-03-31, Astal Laboratories Ltd reported total revenue of ₹64.23Cr, compared with ₹23.65Cr in 2024-03-31, reflecting Astal Laboratories Ltd turnover.

Depreciation was ₹22.31Lakh and finance costs were ₹70.07Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹11.98Cr in 2025-03-31 as compared to ₹1.09Cr in 2024-03-31.

Net Profit (PAT) was ₹8.93Cr in 2025-03-31 compared with ₹78.47Lakh in 2024-03-31.

Earnings per share (EPS) were ₹9.08 in 2025-03-31, compared with ₹0.80 in 2024-03-31.